VeriScout™, our cutting-edge AI solution for critical abnormality detection on brain CT scans, has been approved by the TGA as a Class IIb medical device
04 February 2023
Exciting news at Sydney Neuroimaging Analysis Centre! VeriScout™, our cutting-edge AI solution for critical abnormality detection on brain CT scans, has been approved by the TGA as a Class IIb medical device.
VeriScout™ is fully integrated with RIS and PACS. Together with our TGA-listed informatics solution, Torana™, Veriscout™ seamlessly triages critical brain scans for priority reporting by radiologists.
SNAC is dedicated to improving patient outcomes through state-of-the-art technology and solutions.
To learn more about how VeriScout™ can benefit your practice, please reach out to info@snac.com.au. Let’s work together to have a positive impact on healthcare!